GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NanoEcho AB (publ) (OSTO:NANECH) » Definitions » Net Income From Continuing Operations

NanoEcho AB (publ) (OSTO:NANECH) Net Income From Continuing Operations : kr-10.69 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is NanoEcho AB (publ) Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. NanoEcho AB (publ)'s net income from continuing operations for the three months ended in Dec. 2024 was kr-3.75 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2024 was kr-10.69 Mil.

NanoEcho AB (publ) Net Income From Continuing Operations Historical Data

The historical data trend for NanoEcho AB (publ)'s Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NanoEcho AB (publ) Net Income From Continuing Operations Chart

NanoEcho AB (publ) Annual Data
Trend Dec22 Dec23 Dec24
Net Income From Continuing Operations
-16.61 -14.85 -15.38

NanoEcho AB (publ) Quarterly Data
Dec22 Mar23 Sep23 Dec23 Mar24 Sep24 Dec24
Net Income From Continuing Operations Get a 7-Day Free Trial -2.94 -4.20 -3.98 -2.96 -3.75

NanoEcho AB (publ) Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-10.69 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NanoEcho AB (publ) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NanoEcho AB (publ) (OSTO:NANECH) » Definitions » Net Income From Continuing Operations
Comparable Companies
OSTO:LPGO OSTO:STABL OSTO:QUIA XSAT:RESP OSTO:FLUI XSAT:PHAL XSAT:DBP B XSAT:APTA NGM:DIABIO OSTO:SPRINT VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Scheelevagen 19, Lund, SWE, 223 63
Website
http://www.nanoecho.se
NanoEcho AB (publ) is a Swedish medical technology company. The company is developing a new diagnostic method to track rectal cancer's effect on nearby lymph nodes for the generation of health economic gains. The company's imaging technology is based on a new medical method where nanotechnology is combined with modern ultrasound technology to improve diagnosis methods.

NanoEcho AB (publ) Headlines

No Headlines